Complexity of MS management in the current treatment era

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Neurology

• Publication date

  2018-04-24

• Fields of study

  Medicine

• Identifiers
  DOI 10.1212/WNL.0000000000005399PMID 29686111
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis

  2018influential reference
• SUMMIT (Serially Unified Multicenter Multiple Sclerosis Investigation): creating a repository of deeply phenotyped contemporary multiple sclerosis cohorts

  2018cited by this paper
• Author response: Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology

  2018cited by this paper
• Comprehensive systematic review summary: Disease-modifying therapies for adults with multiple sclerosis

  2018cited by this paper
• Treatment decisions in multiple sclerosis — insights from real-world observational studies

  2017cited by this paper
• Exploration of machine learning techniques in predicting multiple sclerosis disease course

  2017cited by this paper
• Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.

  2017cited by this paper
• Severe, Highly Active, or Aggressive Multiple Sclerosis

  2016cited by this paper
• Defining the clinical course of multiple sclerosis: The 2013 revisions

  2015cited by this paper
• Defining the clinical course of multiple sclerosis

  2014cited by this paper
• Radiologically Isolated Syndrome: 5-Year Risk for an Initial Clinical Event

  2014influential reference
• Demographic and clinical characteristics of malignant multiple sclerosis

  2011cited by this paper

• Disease modifying treatment guidelines for multiple sclerosis in the United Arab Emirates.

  2024cites this paper
• Assessing treatment switch among patients with multiple sclerosis: A machine learning approach

  2023cites this paper
• Prediction of relapse activity when switching to cladribine for multiple sclerosis

  2022cites this paper
• Treatment patterns and comorbid burden of patients newly diagnosed with multiple sclerosis in the United States

  2020cites this paper
• Assessing the Metabolomic Profile of Multiple Sclerosis Patients Treated with Interferon Beta 1a by 1H-NMR Spectroscopy

  2019cites this paper